Abstract
Participant enrollment in clinical trials is challenged by a multitude of structural-, clinical-, physician-, and individual-level barriers to participation.1 In addition to slow clinical trial accrual, there is often under-representation of racial/ethnic minorities who encounter even greater barriers to participation.2,3 The coronavirus disease 2019 (COVID-19) pandemic has further challenged participant enrollment.4 Nationally representative data on attitudes toward clinical trials are limited.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
